Pilot-RCT With Individualized Homeopathic Treatment in the Children With Autism Spectrum Disorder

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

54 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-01

Study Completion Date

2025-01-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study looked at whether homeopathic treatment could help children with Autism Spectrum Disorder (ASD) when used alongside regular therapies like speech and occupational therapy. Over seven years, children between the ages of 2 and 12 were divided into two groups (through computer generated list). One group received individualized homeopathic medicines, and the other received a look-alike placebo (with no active ingredients). Meanwhile, both the groups continued with their regular therapies.

Researchers used various tools and parent questionnaires to track the children's progress in areas like communication, behavior, social skills, daily functioning, toilet training and sensory skills. They found that the children who received homeopathic treatment showed more improvement in these areas compared to those who just received only speech / occupational therapies.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pilot RCT Using Homeopathic Medicines in ASD

NCT07161804

Autism Spectrum Disorder (ASD)

COMPLETED PHASE4

The Effect of Individualised Homoeopathic Treatment of Autism Spectrum Disorder in Children

NCT02363673

Autism Spectrum Disorder

COMPLETED PHASE2

Comparison of Effectiveness of Home Based Sensory Interventions Along With Standard Therapy Versus Standard Therapy Alone in Autistic Children With Sensory Processing Abnormalities

NCT02491645

Autistic Children With Sensory Processing Abnormalities

COMPLETED NA

Combination of Supplements for Treating Autistic Spectrum Disorder

NCT06756711

Autism Spectrum Disorder (ASD

ENROLLING_BY_INVITATION NA

Impact of Air Quality on the Effectiveness of Standard of Care Therapy in Children With Autism Spectrum Disorder: A Prospective Longitudinal Study

NCT06913751

Autism Spectrum Disorder

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Autism Spectrum Disorder (ASD)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HOMOEOPATHIC GROUP

Group Type EXPERIMENTAL

Homoeopathic medicines

Intervention Type DRUG

THERAPY

Intervention Type BEHAVIORAL

SPEECH THERAPY / OCCUPATIONAL THERAPY

CONTROL GROUP

SACCHARUM LACTIS

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

THERAPY

Intervention Type BEHAVIORAL

SPEECH THERAPY / OCCUPATIONAL THERAPY

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Homoeopathic medicines

Intervention Type DRUG

Placebo

Intervention Type DRUG

THERAPY

SPEECH THERAPY / OCCUPATIONAL THERAPY

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

THUJA OFFICINALIS VACCININUM CAUSTICUM ARGENTUM NITRICUM TUBERCULINUM STRAMONIUM STAPHYSAGRIA ARUM TRIPHYLLUM BACILLINUM CINA CARCINOCIN CUPRUM METALLICUM AMBER GRISEA CALCAREA CARBONICA CROCUS SATIVUS HEPAR SULPHUR HYOSCYMUS KALI BROMATUM LAC VACCININUM MEDORRHINUM NATRUM PHOSPHORICUM SACCHARUM LACTIS

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A confirmed diagnosis of Autism Spectrum Disorder (ABC score ≥ 67)
* Age range of 2 to 12 years

Exclusion Criteria

* Children with other significant comorbid psychiatric conditions that could confound the results. \[eg. a brain injury; fragile X syndrome or other syndromes resulting from known genetic defects or inherited metabolic diseases; other diagnosed conditions involving impairments in social and communication abilities, such as intellectual disability without ASD, schizophrenia, language disorders and social communication disorder\]
* Children with irregular follow ups.
* Children with poor medical compliance.

Minimum Eligible Age

3 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No